Correlation Between Nurix Therapeutics and Mustang Bio
Can any of the company-specific risk be diversified away by investing in both Nurix Therapeutics and Mustang Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nurix Therapeutics and Mustang Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nurix Therapeutics and Mustang Bio, you can compare the effects of market volatilities on Nurix Therapeutics and Mustang Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nurix Therapeutics with a short position of Mustang Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nurix Therapeutics and Mustang Bio.
Diversification Opportunities for Nurix Therapeutics and Mustang Bio
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Nurix and Mustang is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Nurix Therapeutics and Mustang Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mustang Bio and Nurix Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nurix Therapeutics are associated (or correlated) with Mustang Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mustang Bio has no effect on the direction of Nurix Therapeutics i.e., Nurix Therapeutics and Mustang Bio go up and down completely randomly.
Pair Corralation between Nurix Therapeutics and Mustang Bio
Given the investment horizon of 90 days Nurix Therapeutics is expected to under-perform the Mustang Bio. But the stock apears to be less risky and, when comparing its historical volatility, Nurix Therapeutics is 1.3 times less risky than Mustang Bio. The stock trades about -0.19 of its potential returns per unit of risk. The Mustang Bio is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 24.00 in Mustang Bio on October 7, 2024 and sell it today you would lose (2.00) from holding Mustang Bio or give up 8.33% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Nurix Therapeutics vs. Mustang Bio
Performance |
Timeline |
Nurix Therapeutics |
Mustang Bio |
Nurix Therapeutics and Mustang Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nurix Therapeutics and Mustang Bio
The main advantage of trading using opposite Nurix Therapeutics and Mustang Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nurix Therapeutics position performs unexpectedly, Mustang Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will offset losses from the drop in Mustang Bio's long position.Nurix Therapeutics vs. Foghorn Therapeutics | Nurix Therapeutics vs. Shattuck Labs | Nurix Therapeutics vs. Monte Rosa Therapeutics | Nurix Therapeutics vs. Kymera Therapeutics |
Mustang Bio vs. Checkpoint Therapeutics | Mustang Bio vs. Reviva Pharmaceuticals Holdings | Mustang Bio vs. Fortress Biotech Pref | Mustang Bio vs. Kodiak Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |